Compare Jasa Armada Indonesia Tbk. (IPCM) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jasa Armada Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Jasa Armada Indonesia Tbk. trades at Rp292 (market cap 1.54T, 801.9K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: Jasa Armada Indonesia Tbk. is far larger — about 2.2× UBC Medical Indonesia Tbk.'s market cap, and Jasa Armada Indonesia Tbk. is more actively traded (801.9K versus 635.5K). Which is the better fit depends on your goals.
| IPCM | LABS | |
|---|---|---|
Market Cap | 1.54T | 691.25B |
Volume | 801.9K | 635.5K |
Lot | 8.02K | 6.36K |
Turnover | 233.61M | 110.15M |
Average Price | 291.32 | 173.33 |
Value | 233.61M | 110.15M |
Indicative Equilibrium Price | 292 | 174 |
Indicative Equilibrium Volume | 34 | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jasa Armada Indonesia Tbk.
PT Jasa Armada Indonesia (“the Company") was established based on Notarial Deed No. 24 dated July 10, 2013 of Nur Muhammad Dipo Nusantara Pua Upa, S.H., M.Kn., notary in Jakarta. The Company’s parent is PT Pelabuhan Indonesia II (Persero) and the Company’s ultimate parent is the Government of the Republic of Indonesia.
Read more on IPCM →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
